St. Luke's MSTI Cancer Care and Research
Awards and Accreditations
St. Luke’s MSTI was re-certified by the Quality Oncology Practice Initiative (QOPI) program, an affiliate of the American Society of Clinical Oncology (ASCO). QOPI certification reflects a commitment to quality of care that leads to fundamental changes in the clinical practice of oncology.
St. Luke’s MSTI was granted our 16th three-year accreditation by the Commission on Cancer (CoC) of the American College
of Surgeons. CoC accreditation provides value through improved patient outcomes across all domains of care: access and service, satisfaction and well-being, quality of care, and cancer outcomes. St. Luke's MSTI has been accredited since 1968.
The Genetic Counseling program at St. Luke’s MSTI was honored with an Innovator Award from the Association of Community Cancer Centers for two quality improvement projects that have increased patient access and patient identification for individuals and families in need of genetic counseling.
The Blood and Marrow Transplant Program at St. Luke's MSTI in Boise earned our fifth accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT), an organization that establishes international standards for high quality patient care, cell storage, and lab practices.
St. Luke’s MSTI received an Innovator Award from the Association of Community Cancer Centers for our multidisciplinary Supportive Oncology Clinic that improves access to early palliative care for patients with advanced cancer.
Thomas M. Beck, MD was honored with the Association of Community Cancer Centers' David King Community Clinical Scientist Award for his outstanding service, leadership, and commitment to the oncology community.
St. Luke’s Medical Imaging received accreditation for breast MRI by the American College of Radiology (ACR). St. Luke's is also accredited in CT, MRI, ultrasound, mammography, and nuclear medicine. ACR accreditation assures patients, referring physicians, and payers that St. Luke's Medical Imaging facilities have undergone a rigorous review process and meet nationally accepted standards of care.
St. Luke’s MSTI was honored with an Innovator Award by the Association of Community Cancer Centers for our Oral Chemotherapy program.
Medical oncologist Banu Symington, MD was honored by the Cancer Therapy Evaluation Program (CTEP) for clinical trials participation.
St. Luke's MSTI earned our third Magnet recognition by the American Nurses Credentialing Center.The gold standard for nursing services, Magnet reflects the highest level of nursing and patient care excellence in the nation.
St. Luke’s MSTI was selected by the National Cancer Institute to join its Community Cancer Centers Program (NCCCP). As an NCCCP contract recipient, St. Luke's MSTI will continue working to reduce cancer care disparities and improve access to high quality care and clinical trials for our region.
St. Luke’s MSTI was one of the first cancer centers in the U.S. to be recognized by the Quality Oncology Practice Initiative (QOPI) certification program, an affiliate of the American Society of Clinical Oncology, for meeting rigorous standards for high quality cancer care.
The Blood and Marrow Transplant Program at St. Luke's MSTI in Boise is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).
St. Luke's Center for Breast Imaging was recognized by the American College of Radiology (ACR) and the Society of Breast Imaging with a 2007 Breast Imaging Center of Excellence Award. The only center in Idaho to receive this award, St. Luke's was honored for meeting all of the ACR's breast-related accreditation standards.
St. Luke’s MSTI was awarded the Idaho Hospital Association’s 2007 Citation for Meritorious Service, for 40 years of dedication to the study, prevention, and treatment of cancer, and the contemporary, comprehensive, and compassionate care we provide our patients.
St. Luke’s MSTI was one of only 12 practices in the country to receive the American Society of Clinical Oncology (ASCO) 2006 Clinical Trials Participation Award, in recognition of our important contributions to improve the care of people with cancer through participation in clinical trials.
St. Luke's MSTI was recognized by Avatar International Inc., with an Exemplary Service/Overall Best Performer Award. St. Luke's was recognized as one of 10 organizations out of more than 300 hospitals in our bed-size category (300-400 beds) with the highest combined outpatient, ambulatory surgery, ED, and inpatient patient satisfaction scores.